JoanHSchillerMD

Oncology • Fairfax, VA

Hematologic Oncology, Thoracic Cancer

Oncologist at Inova Schar Cancer Institute

Join to view full profile

Dr. Schiller is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Schiller's full profile

Already have an account?

Office
8501 Arlington Blvd
Fairfax, VA 22031
Phone(703) 970-6431
Fax(703) 970-6429
Is this information wrong?

Education & Training

University of WisconsinFellowship, Medical Oncology, 1983 - 1987
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1980 - 1983
University of Illinois College of MedicineClass of 1980

Certifications & Licensure

VA State Medical License 2016 - 2022
TX State Medical License 2007 - 2016
WI State Medical License 1983 - 2011
IL State Medical License 1981 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Genome-Wide Methylation and Gene Re-expression Analysis of Resectable Lung Tumor Tissue Pairs Obtained Pre- and Post-Treatment With 5-Azacytidine and Entinostat Start of enrollment: 2013 Jun 01Schiller, J.H.,Jones, D.V.
Adjuvant De-escalation, Extracapsular Spread, P16+, Transoral (A.D.E.P.T.) Trial for Oropharynx Malignancy Start of enrollment: 2013 Jan 01Matthew Zarka, M.D., Kelly Curtis, M.D., Samir Patel, M.D., Michael Hinni, M.D., Hiram Gay, M.D., Wade Thorstad, M.D., Douglas Adkins, M.D., Tanya Wildes, M.D., Loren Michel, M.D., James Lewis, Jr., M.D.,...
A Study of HSP90 Inhibitor AT13387 Alone and in Combination With Crizotinib in the Treatment of Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2012 Oct 01Helen Ross, MD, Lyudmila Bazhenova, MD, Barbara Gitlitz, MD, David Bodkin, MD, Jonathan Goldman, MD, Merrill Shum, MD, Ross Camidge, Scott Gettinger, MD, Michael Guarino, Tarek Mekhail, Alberto Chiappori,...
BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2010 Dec 01Constantinou, C.L.,Wender, D.B.,Friedman, E.L.,Schneiderman, E.C.,Schnell, F.M.,Soori, G.S.,Strauss, G.M.,Wakelee, H.A.,Wagner, H.,Oliff, I.,Schiller, J.H.,Kugler, J.W.,Bufill, J.A.,Patel, J.D.,Haut, M.,P...
A Randomized Phase II Study of Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy for Advance Non-small Cell Lung Cancer(NSCLC) Start of enrollment: 2010 May 01Belur, M.,Blaney, M.,Bone, A.,Farley, C.,Fenske, E.,Fulgham, P.,Garcia, E.,Gauer, D.,Giard, K.,Goldstein, D.,Gowland, P.,Gramberg, M.,Hackstock, D.,Hager, C.,HELTON, S.,Long, D.,Lynch, L.,Meyer, O.,Mondug...
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4cm)-IIIA Non-Small Lung Cancer (NSCLC) Start of enrollment: 2007 Jun 01Adjei, A.A.,Advani, A.S.,Agarwala, S.S.,Ahmed, S.,Alden, M.,Alexson, E.R.,Almokadem, S.M.,Anderson, N.R.,Ansari, B.,Ash, R.C.,Atkins, J.N.,Averbook, B.J.,Axelrod, R.S.,Aziz, S.,Barai, B.H.,Bauman, J.E.,Ba...
Randomized, Phase II,Open-Label Controlled Study of Two Different Doses and Schedules of EMD 72000 (Matuzumab) in Combination With Pemetrexed, or Pemetrexed Alone, as Second-Line Treatment for Stage IIIB/IV Non-Small Cell Lung Cancer and Progressive Disea Start of enrollment: 2005 Aug 01Schiller, J.,Socinski, M.
Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer Start of enrollment: 2003 May 01Schiller, J.H.
Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer Start of enrollment: 2000 Jan 01Schiller, J.H.
Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer Start of enrollment: 1999 Feb 01Schiller, J.H.
Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer Start of enrollment: 1997 Jul 01Schiller, J.H.
An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Oral LDK378 in Adult Patients With Non-small Cell Lung Cancer (NSCLC) Characterized by ALK Positivity Erlich, R.B.,Payne, J.E.,Graham, R.M.,Baik, C.S.,Rettig, M.,Byeff, P.D.,Male, H.J.,Gutierrez, M.E.,Shirai, K.,Sharma, S.,Bazhenova, L.A.,Slater, D.,Stilwill, J.,Kumar, P.,Hutchins, M.R.,Pickens, P.V.,John...
Join now to see all

Publications & Presentations

PubMed

Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (N...
Jyoti D. Patel, Ju-Whei Lee, David P. Carbone, Henry N. Wagner, Anil Shanker, Maria Teresa P. de Aquino, Leora Horn, Melissa Lynne Johnson, David E. Gerber, Jane Jijun...> ;Clinical Lung Cancer. 2020 Jun 12
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
Nasser H. Hanna, Bryan J. Schneider, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Laurie E. Gaspar, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, I...> ;Journal of Clinical Oncology. 2020 Jan 28
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer.
Gerber, D. E., Infante, J. R., Gordon, M. S., Goldberg, S. B., Martín, M., Felip, E., Garcia, M. M., Schiller, J. H., Spigel, D. R., Cordova, J., Westcott, V., Wang, Y...> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Sep 22
Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: ECOG-ACRIN 5508
Suresh S. Ramalingam, Suzanne E. Dahlberg, Chandra P. Belani, Joel N. Saltzman, Nathan A. Pennell, Gopakumar S. Nambudiri, John McCann, Jerome D. Winegarden, Mohammed ...> ;Journal of Clinical Oncology. 2019 Jul 30
Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer.
Tao Wang, Rong Lu, Sunny Lai, Joan H. Schiller, Fang Liz Zhou, Bo Ci, Stacy Wang, Xiaohan Gao, Bo Yao, David E. Gerber, David H. Johnson, Guanghua Xiao, Yang Xie> ;Cancer Informatics. 2019 Apr 5
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.
David E. Gerber, Mark A. Socinski, Joel W. Neal, Heather A. Wakelee, Keisuke Shirai, Lecia V. Sequist, Rachel P. Rosovsky, Rogerio Lilenbaum, Bruno R. Bastos, Chao Hua...> ;Lung Cancer. 2018 Mar 1
21 citations
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial
Heather A. Wakelee, Suzanne E. Dahlberg, Steven M. Keller, William Tester, David R. Gandara, Stephen L. Graziano, Alex A. Adjei, Natasha B. Leighl, Seena Aisner, Jan M...> ;Lancet Oncology. 2017 Dec 1
Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung can...
Athanassios Argiris, Ju-Whei Lee, James P. Stevenson, M. Sulecki, V. Hugec, Nicholas Choong, Joel N. Saltzman, W. Song, R. M. Hansen, Tracey L. Evans, Suresh S. Ramali...> ;Annals of Oncology. 2017 Dec 1
JNCI: Journal of the National Cancer Institute
Joan Schiller, MD> ;Journal of the National Cancer Institute. 2017 Oct 19
Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients.
Thomas J. Smith, Nasser H. Hanna, David H. Johnson, Sherman Baker, William A. Biermann, J. Brahmer, Peter M. Ellis, Giuseppe Giaccone, Paul J. Hesketh, Ishmael Jaiyesi...> ;Journal of Oncology Practice. 2017 Oct 5
17 citations
Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non–Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients ...
Thomas E. Stinchcombe, Ying Zhang, Everett E. Vokes, Joan H. Schiller, Jeffrey D. Bradley, Karen Kelly, Walter J. Curran, Steven E. Schild, Benjamin Movsas, Gerald H. ...> ;Journal of Clinical Oncology. 2017 Sep 1
9 citations
Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.
Garcia, S., Bisen, A. K., Yan, J., Xie, X., Ramalingam, S. S., Schiller, J. H., Johnson, D. H., Gerber, D. E.> ;Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017 Aug 15
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Hanna, N.,Johnson, D.,Temin, S.,Baker, S.,Brahmer, J.,Ellis, P. M.,Giaccone, G.,Hesketh, P. J.,Jaiyesimi, I.,Leighl, N. B.,Riely, G. J.,Schiller, J. H.,Schneider, B. J...> ;J. Clin. Oncol.. 2017 Aug 15
3 citations
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygen...
Martin J. Edelman, Xiaofei Wang, Lydia Hodgson, Richard T. Cheney, Maria Q. Baggstrom, Sachdev P. Thomas, Ajeet Gajra, Erin M. Bertino, Karen L. Reckamp, Julian R. Mol...> ;Journal of Clinical Oncology. 2017 May 10
Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies
Hao Tang, S. Wang, Guanghua Xiao, Joan H. Schiller, Vassiliki A. Papadimitrakopoulou, John D. Minna, I. I. Wistuba, Yang Xie> ;Annals of Oncology. 2017 Apr 1
PS01.02: Thoracic Oncology Clinical Trial Eligibility Criteria: Ongoing Increase inÂ Recent Years: Topic: Medical Oncology.
Gerber, D. E., Garcia, S., Yan, J., Xie, X., Ramalingam, S. S., Schiller, J. H., Johnson, D. H.> ;Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016 Dec 15
PS01.54: Evaluation of Novel Blood-Based Biomarkers with Atezolizumab Monotherapy in 1L Advanced or Metastatic NSCLC (B-F1RST): Topic: Medical Oncology.
Socinski MA, Schiller J, Dakhil S, Kazmi S, Leach J, Hu S, Paul SM, Shames DS, Phan S, Yun C, Velcheti V> ;J Thorac Oncol. 2016-11-01
Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBr...
C. J. Langer, Mark A. Socinski, Jyoti D. Patel, Alan Sandler, Joan H. Schiller, Larry Leon, Sebastien Hazard, Suresh S. Ramalingam> ;American Journal of Clinical Oncology. 2016 Oct 1
2 citations
Resolving Rivalries and Realigning Goals: Challenges of Clinical and Research Multiteam Systems
David E. Gerber, Torsten Reimer, Erin L. Williams, Mary Gill, Laurin L. Priddy, Deidi Bergestuen, Joan H. Schiller, Haskell Kirkpatrick, Simon J. Craddock Lee> ;Journal of Oncology Practice. 2016 Sep 13
3 citations
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research...
Chandra P. Belani, Suzanne E. Dahlberg, Charles M. Rudin, Martin Fleisher, Helen X. Chen, Naoko Takebe, Mario R. Velasco, William Tester, Keren Sturtz, Christine L. Ha...> ;Cancer. 2016 Aug 1
1 citations
Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
Frink, R. E., Peyton, M., Schiller, J. H., Gazdar, A. F., Shay, J. W., Minna, J. D.> ;Oncotarget. 2016 May 19
1 citations
Attitudes and Stereotypes in Lung Cancer versus Breast Cancer.
N. Sriram, Jennifer Mills, Edward Lang, Holli K. Dickson, Heidi A. Hamann, Brian A. Nosek, Joan H. Schiller> ;PLOS ONE. 2015 Dec 23
9 citations
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer
David E. Gerber, David A. Boothman, Farjana J. Fattah, Ying Dong, Hong Zhu, Rachel A. Skelton, Laurin L. Priddy, Peggy Vo, Jonathan E. Dowell, Venetia R Sarode, Richar...> ;Lung Cancer. 2015 Dec 1
171 citations
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Gregory A Masters, Sarah Temin, Christopher G Azzoli, Giuseppe Giaccone, Sherman Baker Jr, Julie R Brahmer, Peter M Ellis, Ajeet Gajra, Nancy Rackear, Joan H Schiller,...> ;Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Oct 20
13 citations
The Urgent Need for Clinical Research Reform to Permit Faster, Less Expensive Access to New Therapies for Lethal Diseases
David J. Stewart, Gerald Batist, Hagop M. Kantarjian, John Peter Bradford, Joan H. Schiller, Razelle Kurzrock> ;Clinical Cancer Research. 2015 Oct 15
Join now to see all

Lectures

American Society for Radiation Oncology(ASTRO): 20th Chicago Multidisciplinary Symposium inThoracic Oncology
American Society for Radiation Oncology, Chicago, Illinois - 9/6/2012

Press Mentions

Survey Shows Lung Cancer Stigma Has Decreased, More Awareness Still NeededSeptember 24th, 2019
Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects NonsmokersOctober 24th, 2017
South Carolina Alumnus Elected to Board of the National Association of EMS Physicians (ASPH -February 18th, 2016
Join now to see all

Grant Support

Physician Scientist Oncology Training ProgramNational Cancer Institute2009–2011
Nm-404 As An Imaging Agent In Patients With Non-Small Cell Lung CancerNational Center For Research Resources2005–2006
Safety And Efficacy Of Abx-Egf, Paclitaxel And Carboplatin In NsclcNational Center For Research Resources2005
Pilot Study Of Liquid Crystal Nano-Structured Surfaces (Lc/Ns) AnalysesNational Center For Research Resources2005
Clinical Academic Oncologist Training ProgramNational Cancer Institute2005
Initial Human Safety Evaluation Of Nm404National Center For Research Resources2004–2005
Nano-Structure Surfaces And Liquid Crystal AnalysisNational Cancer Institute2004–2005
Safety And Efficacy Of ABT-510 PLUS Combination Chemotherapy In NsclcNational Center For Research Resources2004
Mid Career Investigator AwardNational Cancer Institute2000–2004
Academic Clinical Oncologist Training ProgramNational Cancer Institute2000–2004
CCNU In Nsclc Patients With Methylation Of The Mgmt GeneNational Cancer Institute2001–2003
Nm-404 A Novel Imaging Agent In Lung CancerNational Cancer Institute2002
Phase I Trial Of Docetaxel &KNational Center For Research Resources1999–2002
Phase I/II Trial Of Amifostine, High Dose Cisplatin, And Docetaxel In NsclcNational Center For Research Resources1998–2002
Phase III Randomized Study Of Intensive Cisplatin And Vinblastin +/- AmifostineNational Center For Research Resources1996–2002
Zeneca Zd0473 Combined With Topotecan In PTS W Refractory Solid MalignanciesNational Center For Research Resources2000
Msi-1256f (Squalamine Lactate) , Carboplatin, Paclitaxil In Nonsmal Cell Lung CanNational Center For Research Resources2000
Etoposide, Cisplatin, And Paclitaxel In Extensive SCLCNational Center For Research Resources2000
Adenovirus P53 In Bronchio-Alveolar Cell Lung CarcinomaNational Center For Research Resources2000
Squalamine PLUS Carboplatin And Paclitaxel In NSC Lung CNational Cancer Institute1999–2000
Phase I Evaluation Of CGP 69846a (Isis 5132)National Center For Research Resources1997–1999
Phase I Evaluation Of CGP 69846aNational Center For Research Resources1997–1999
Phase Ib/Ii Gmcsf And IL 2 In Renal Cell Carcinoma With Pulmonary MetastasesNational Center For Research Resources1996–1999
Clinical Testing Of Local BRM Delivery By Particle Mediated Gene TransferNational Cancer Institute1996–1999
Comparison Of Oral Ondansetron And IV Granisetron To Prevent Nausea &VomitingNational Center For Research Resources1997
Randomized Double Blind Comparison Of Oral Ondansetron And IV GranisetronNational Center For Research Resources1996
Phase II/III Randomized Study Of Cisplatin/Vinblastine PLUS Or Minus EthyolNational Center For Research Resources1995–1996
Cisplatin/Vinblastine And WR2721 PLUS Radiotherapy And WR2721 In NsclcNational Center For Research Resources1995–1996
Cisplatin In Hypertonic Saline, Vinblastine And Ethyol In Lung CancerNational Center For Research Resources1995–1996
Pilot Study Of Cisplatin/Vinblastine/Wr2721 Administered Without CI MannitolNational Center For Research Resources1995
Phase IB Granulocyte Macrophage Colony Stimulating Factor And IL2National Center For Research Resources1995
Laboratory-Clinical Correlative Studies In Lung CancerNational Cancer Institute1993–1995